Amy E Colson MD
Clinical Instructor in Medicine, Cambridge Health Alliance
Join to View Full Profile
1493 Cambridge StZinberg ClinicCambridge, MA 02139
Phone+1 617-665-1606
Dr. Colson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 1996 - 1999
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1993 - 1996
Harvard Medical SchoolClass of 1993
Certifications & Licensure
MA State Medical License 1996 - 2027
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 364 citationsLedipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1Susanna Naggie, Curtis Cooper, Michael S. Saag, Kimberly A. Workowski, Peter Ruane
The New England Journal of Medicine. 2015-08-19 - 5 citationsSimilar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients.Daniel J. Skiest, Calvin J. Cohen, Karam Mounzer, Zach Haigney, David Barker
HIV Clinical Trials. 2011-05-01 - 3 citationsLetter to the Editor: Durable Suppression Possible with FOTO Treatment Schedule in Subjects on Nevirapine-Based RegimensCal Cohen, Amy E. Colson
HIV Clinical Trials. 2007-07-01
Press Mentions
Top 5 HIV Treatment Stories from CROI 2024March 19th, 2024- Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), an Investigational, Once-Daily, Two-Drug Regimen for the Treatment of Adults Living with HIV-1 at CROI 2026February 26th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
